Magnesium-loosing diuretics: Thiazides

Version vom 13. Dezember 2021, 09:52 Uhr

pubmed xx

32603001 2021. Mechanisms coupling sodium and magnesium reabsorption in the distal convoluted tubule of the kidney.
33135481 2020. NaCl cotransporter activity and Mg(2+) handling by the distal convoluted tubule.
28274923 2017. Effect of diuretics on renal tubular transport of calcium and magnesium.
26582761 2016. The role of calbindin-D28k on renal calcium and magnesium handling during treatment with loop and thiazide diuretics.
23427142 2013. Loss of WNK3 is compensated for by the WNK1/SPAK axis in the kidney of the mouse.
21653632 2011. Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment.
11704552 2001. Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron.
10997911 2000. Divalent cation transport by the distal nephron: insights from Bartter's and Gitelman's syndromes.
18816383 2008. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): compound heterozygous mutation in the claudin 16 (CLDN16) gene.
7818648 1994. Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension.
3044503 1988. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.
8373706 1993. Do diuretics cause magnesium deficiency?
8485017 1993. A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.
6401495 1983. Diuretic associated hypomagnesaemia.
29061124 2017. Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study.
21030577 2011. Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations.
25589264 2015. Distal convoluted tubule.
19229529 2009. Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis.
10922295 2000. Epithelial magnesium transport and regulation by the kidney.
15206555 2004. Depressive state and paresthesia dramatically improved by intravenous MgSO4 in Gitelman's syndrome.
11518780 2001. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
10073595 1999. Dietary magnesium, not calcium, regulates renal thiazide receptor.
16227760 2005. The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.
15902302 2005. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia.
4338123 1972. The interactions of thiazide diuretics with parathyroid hormone and vitamin D. Studies in patients with hypoparathyroidism.
27759579 2017. Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women.
2340945 1990. Renal excretory actions of furosemide, of hydrochlorothiazide and of the vasodilator flosequinan in healthy subjects.
18681815 2008. Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial.
9398030 1997. Urinary calcium excretion and renal calbindin-D28k.
17928827 2007. Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia.
10886578 2000. Interaction of cyclosporine and FK506 with diuretics in transplant patients.
9350641 1997. Renal magnesium handling: new insights in understanding old problems.
9186858 1997. Phosphate depletion diminishes Mg2+ uptake in mouse distal convoluted tubule cells.
9083264 1997. Cellular mechanisms of chlorothiazide and cellular potassium depletion on Mg2+ uptake in mouse distal convoluted tubule cells.
8887276 1996. Thiazide treatment of rats provokes apoptosis in distal tubule cells.
3035268 1987. Effects of hydrochlorothiazide on Na-K-ATPase activity along the rat nephron.
31088779 2018. Magnesium and thiazide diuretics.
23657239 2013. Hydrochlorothiazide and high-fat diets reduce plasma magnesium levels and increase hepatic oxidative stress in rats.
21983221 2011. Role of the distal convoluted tubule in renal Mg2+ handling: molecular lessons from inherited hypomagnesemia.
23144069 2012. Parvalbumin: calcium and magnesium buffering in the distal nephron.
16595585 2006. Hydrochlorothiazide in CLDN16 mutation.
33500669 2021. Identification of Predictors of Abnormal Calcium, Magnesium and Phosphorus Blood Levels in the Emergency Department: A Retrospective Cohort Study.
10638687 1999. Acute effect of hydrochlorothiazide on renal calcium and magnesium handling in postmenopausal women.
11152754 2001. Magnesium transport in the renal distal convoluted tubule.
29799851 2018. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
16865329 2006. Total cellular calcium and magnesium content of cultured human peripheral blood mononuclear cells following exposure to antidiabetic drugs.
3414406 1988. Amiloride prevents thiazide-induced intracellular potassium and magnesium losses.
4091044 1985. Renal excretion of electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure.
1096542 1975. The effect of hydrochlorothiazide and amiloride administered together on muscle electrolytes in normal subjects.
4749172 1973. The effect of bendroflumethiazide on the renal handling of calcium, magnesium and phosphate in normocalcaemic renal stone formers and in hyperparathyroidism.
6959477 1982. Effect of moduretic and aldactone on electrolytes in skeletal muscle in patients on long-term diuretic therapy.
6324542 1984. Problems with potassium and magnesium in diuretic-treated patients.
5679807 1968. Effects of hydrochlorothiazide on plasma electrolyte levels in normal and parathyroidectomized dogs.
8036903 1994. Magnesium and potassium deficiency. Its diagnosis, occurrence and treatment in diuretic therapy and its consequences for growth, protein synthesis and growth factors.
3551542 1986. Dissociation between the hypotensive effect of thiazides and plasma divalent cations.
1103593 1975. Disease of the parathyroid glands.
3739851 1986. The metabolic effects of thiazide therapy in the elderly: a population study.
717235 1978. Leukocyte intracellular cations in hypertension: Effect of antihypertensive drugs.
1414894 1992. Electrolyte balance in heart failure and the role for magnesium ions.
1329470 1992. Effects of hydrochlorothiazide, amiloride, and lisinopril on the metabolic, hemodynamic, and electrocardiographic responses to increased plasma epinephrine.
1951126 1991. Effects of hydrochlorothiazide, diltiazem and enalapril on mononuclear cell sodium and magnesium levels in systemic hypertension.
2643290 1989. Efficacy and safety of triamterene/hydrochlorothiazide combinations in mild systemic hypertension.
2705372 1989. Thiazide treatment of systemic hypertension: effects on serum magnesium and ventricular ectopic activity.
6421137 1984. Diuretic therapy for mild hypertension: the "real" cost of treatment.
31086 1978. Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascites.
4061439 1985. Relationship of diuretic therapy and serum magnesium levels among participants in the Multiple Risk Factor Intervention Trial.
18174757 2008. Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy.
17586417 2007. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
15797654 2005. The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study.
12160198 2002. Skeletal muscle magnesium content is correlated with plasma glucose concentration in patients with essential hypertension treated with lisinopril or bendrofluazide.
8695028 1996. The blood pressure response to antihypertensive treatment with lisinopril or bendrofluazide is related to the calcium and magnesium contents in skeletal muscle.
1418829 1992. Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients.
26830254 2016. Thiazide Responsiveness Testing in Patients With Renal Magnesium Wasting and Correlation With Genetic Analysis: A Diagnostic Test Study.
16632016 2006. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors.
10401023 1999. Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
7977315 1994. Magnesium deficiency: pathophysiologic and clinical overview.
11893352 2002. Genetic forms of renal potassium and magnesium wasting.
2571295 1989. Renal excretory actions of antihypertensive agents. Effects of rilmenidine.
2729315 1989. Prior treatment with diuretic augments the hypokalemic and electrocardiographic effects of inhaled albuterol.
3565425 1987. Serum magnesium and potassium levels in hypertensive patients after a therapeutic switch from hydrochlorothiazide plus a potassium supplement to maxzide.
3706351 1986. Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy.
6496557 1984. Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension.
10653441 2000. Diuretic complications.
9481438 1998. Studies on the pathogenesis of hypokalemia in Gitelman's syndrome: role of bicarbonaturia and hypomagnesemia.
2870642 1986. Problems with the use of diuretics in the treatment of hypertension.
9227637 1997. Acid-base changes alter Mg2+ uptake in mouse distal convoluted tubule cells.
6548610 1984. Mechanism of chronic hypocalciuria with chlorthalidone: reduced calcium absorption.
5545694 1971. Renal transport of Na, Ca, Mg, and K during volume expansion and distal blockade.
16645424 2006. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.
10423646 1999. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
2831788 1987. Combined action of enalapril or timolol with hydrochlorothiazide plus amiloride in hypertension.
3789649 1986. Cardiac arrhythmias in hypertensive outpatients on various diuretics. Correlation between incidence and serum potassium and magnesium levels.
3521443 1986. Comparison of low doses of hydrochlorothiazide plus amiloride and hydrochlorothiazide alone in hypertension in elderly patients.
10528423 1999. Magnesium and cardiovascular drugs: interactions and therapeutic role.
3632162 1987. The value of serum magnesium determination in hypertensive patients receiving diuretics.
3662705 1987. Diuretic-associated hypomagnesemia in the elderly.
3963971 1986. Magnesium depletion and thiazide hypokalemia.
3521522 1986. Intracellular cations and diuretic therapy following acute myocardial infarction.
2867747 1986. Fluid and electrolyte considerations in diuretic therapy for hypertensive patients with chronic obstructive pulmonary disease.
3144955 1988. Hypokaliemie, hypomagnesemie et arythmies ventriculaires au cours du traitement diuretique de l'hypertension arterielle.
10429815 1999. Hypomagnesemie, hypercalciurie et nephrocalcinose de revelation precoce: deux observations familiales.
1823750 1991. Magnesio mononuclear em hipertensos idosos tratados com tiazidico.
29158115 2017. Trace elements cause oxidative damage in the brain of rats with induced hypotension.
7994447 1994. Relation between low dose of hydrochlorothiazide, antihypertensive effect and adverse effects.
7151011 1982. Effect of chlorothiazide on renal calcium and magnesium handling in the hamster.
10754345 1999. Pearls and pitfalls in the use and abuse of diuretics for chronic congestive heart failure.
7954546 1994. Metabolic effects of diuretics.
3342421 1988. Influence of chronic diuretic therapy on serum, lymphocyte and erythrocyte potassium, magnesium and calcium concentrations.
1322162 1992. Effects of hydrochlorothiazide, amiloride, and lisinopril on the metabolic response to adrenaline infusions in normal subjects.
16272623 2005. Potassium and magnesium depletions in congestive heart failure--pathophysiology, consequences and replenishment.
2832105 1988. Effects of thiazide on erythrocyte sodium and potassium concentrations and Na+K+ATPase in hypertensive patients.
11076102 2000. Correction of thiazide-induced hypomagnesemia by potassium-magnesium citrate from review of prior trials.
3880686 1985. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
5455635 1970. Effects of large and small doses of hydrochlorothiazide in hypertensive patients.
4259118 1972. Distribution and properties of Na + ,K + -ATPase in human post-mortem kidney and the effects of diuretics.
5772103 1969. The acute effects of mersalyl, chlorothiazide and mannitol on the renal excretion of calcium and other ions in man.
14236783 1964. THE EFFECT OF BENDROFLUAZIDE ON URINE CALCIUM EXCRETION.
2156644 1990. Electrocardiographic changes induced by inhaled salbutamol after treatment with bendrofluazide: effects of replacement therapy with potassium, magnesium and triamterene.
2880664 1986. Spironolactone in the management of congestive cardiac failure: a review.

16119971 2005. Drug-induced hypomagnesaemia : scope and management.
1418693 1992. Adverse effects of diuretics.
31847050 2020. Risk variables associated with abnormal calcium, magnesium and phosphate levels among emergency department patients.
1318845 1992. A comparison of the effect of lisinopril and hydrochlorothiazide on electrolyte balance in essential hypertension.
2076714 1990. Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.
3402518 1988. The effect of diuretic therapy on adrenaline-induced hypokalaemia and hypomagnesaemia.
3366161 1988. Effects of triamterene on serum and skeletal muscle electrolytes in diuretic-treated patients.
2886340 1987. Magnesium depletion in patients on long-term chlorthalidone therapy for essential hypertension.
6541131 1984. Diurnal variation of urine composition in calcium oxalate stone disease during treatment with bendroflumethiazide.
6706271 1984. Untersuchungen zur Elektrolyt-Ausscheidung nach Gabe verschiedener Diuretika bei gesunden Frauen.
3428842 1987. Magnesuria induced by thiazides and the influence of triamterene.
3440524 1987. Arrhythmias, electrolytes, and ACE inhibitor therapy in the elderly.
16804318 2006. An unusual patient with hypercalciuria, recurrent nephrolithiasis, hypomagnesemia and G227R mutation of Paracellin-1. An unusual patient with hypercalciuria and hypomagnesemia unresponsive to thiazide diuretics.
2120260 1990. Thiazides: the true benefit-risk ratio.
15310530 2004. Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy.
2477338 1989. The effect of potassium and potassium plus magnesium supplementation on ventricular extrasystoles in mild hypertensives treated with hydrochlorothiazide.
3045028 1988. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene.
3301983 1987. Magnesium and hypertension.
14147001 1964. MAGNESIUM METABOLISM.
8583780 1995. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure.
2441176 1987. Effect of chronic diuretics on epinephrine-induced ventricular arrhythmias: a comparison of hydrochlorothiazide and amiloride in the rat.
2580178 1985. Effects of captopril, hydrochlorothiazide, and their combination on timed urinary excretions of water and solutes.
9824785 1998. The effect of varying molar ratios of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
8750365 1995. Ramipril decreases chlorthalidone-induced loss of magnesium and potassium in hypertensive patients.
2050832 1991. Hydrochlorothiazide versus spironolactone: long-term metabolic modifications in patients with essential hypertension.
2401750 1990. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide.
721950 1978. Interrelationships among thiazide diuretics and calcium, magnesium, sodium, and potassium balance in normal and hypertensive man.
2592738 1989. Direct tubular effect on calcium retention by hydrochlorothiazide.
21107435 2011. Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension.
11986901 2002. Diuretics in the therapy of hypertension.
2657056 1989. Twice-daily low-dose captopril in diuretic-treated hypertensives.
1316396 1992. Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death.
2213284 1990. The cardiotoxicity of thiazide diuretics: review of the evidence.
3553482 1986. Amiloride with or without salbutamol versus placebo: effects on lipoproteins in hypertensive patients treated with timolol-hydrochlorothiazide.
16099237 2005. Responses in extracellular and intracellular calcium and magnesium in aldosteronism.
5434005 1970. Effect of diuretics on urinary excretion of phosphate, calcium, and magnesium in thyroparathyroidectomized dogs.
7536804 1995. Cyclothiazide modulates AMPA receptor-mediated increases in intracellular free Ca2+ and Mg2+ in cultured neurons from rat brain.
13914453 1962. Magnesium depletion induced by various diuretics.
27191077 2016. Re: The Role of Calbindin-D28k on Renal Calcium and Magnesium Handling during Treatment with Loop and Thiazide Diuretics.
7299925 1981. Metabolic effects of bendroflumethiazide in patients with recurrent calcium oxalate stone disease.
1735925 1992. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men.
682307 1978. Thiazide-induced hypomagnesemia.
14242424 1965. MAGNESIUM METABOLISM IN HYPERTENSION.
3225892 1988. Intracellular magnesium deficiency and effect of oral magnesium on blood pressure and red cell sodium transport in diuretic-treated hypertensive patients.
2038173 1991. Pharmacodynamic and kinetic considerations on diuretics as a basis for differential therapy.
3999630 1985. Skeletal muscle water and electrolytes in treated and untreated essential hypertension.
2987608 1985. Mechanism of diuretic-induced hypopotassemia in human hypertension.
13899152 1962. [Magnesium, calcium and phosphorus balances in essential hypertension and heart insufficiency in the treatment with hydrochlorothiazide].
1591140 1992. Triamterene may preserve lymphocyte magnesium and potassium in patients with congestive heart failure.
2132750 1990. Angiotensin converting enzyme inhibitors, thiazide diuretics and magnesium balance. A preliminary study.
2755214 1989. Comparison of potassium alone and potassium-magnesium supplementation in patients with heart failure using hydrochlorothiazide.
3244283 1988. Diuretic-induced CNS magnesium alteration and digoxin intoxication.
3543514 1986. Magnesium and potassium-sparing diuretics.
4079463 1985. The myth of long-term thiazide-induced magnesium deficiency.
6482509 1984. Role of dietary potassium and magnesium in diuretic-treated patients with cardiac insufficiency.
3520260 1986. Complications of thiazide diuretic therapy: an update.
5652621 1968. Effects of chlorothiazide and amipramizide (MK 870) on the renal excretion of calcium, phosphate and magnesium.
3320720 1987. Renal-metabolic consequences of antihypertensive therapy with diltiazem versus hydrochlorothiazide.
24092847 2013. The impact of dietary magnesium restriction on magnesiotropic and calciotropic genes.
16221718 2006. Gitelman syndrome: genetic and expression analysis of the thiazide-sensitive sodium-chloride transporter in blood cells.
15069170 2004. Four novel mutations in the thiazide-sensitive Na-Cl co-transporter gene in Japanese patients with Gitelman's syndrome.
15008072 2004. Renal handling of phosphorus and magnesium.
32622651 2020. Syndromes de Bartter-Gitelman.
6308488 1983. Influence a court terme des thiazides sur le metabolisme du magnesium, du calcium et accessoirement sur celui du phosphore, de l'acide urique, de l'oxalate et de l'AMP cyclique.
11015018 2000. Aldosterone influences serum magnesium in Gitelman syndrome.
9423927 1997. The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: modulation by cyclothiazide, interaction with GABA and the behavioural consequences.
865730 1977. The management of severe preeclampsia and eclampsia with intravenous diazoxide.
18425402 2008. Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons.
8865231 1996. Linkage of Gitelman syndrome to the thiazide-sensitive sodium-chloride cotransporter gene with identification of mutations in Dutch families.
18949482 2009. Regulation of magnesium reabsorption in DCT.
30095199 2018. Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population.
3406047 1988. Acute effect of indapamide on urine calcium excretion in nephrolithiasis and human essential hypertension.
3602017 1986. The effects of bendroflumethiazide/potassium chloride versus hydrochlorothiazide/amiloride on blood pressure and serum electrolytes in patients with mild to moderate hypertension seen in general practice.
133359 1976. Effect of single dose of diuretics on renal magnesium excretion in man, with special reference to their site of action.
1669148 1991. Hydrochlorothiazyd, allopurinol i tlenek magnezowy w leczeniu nawrotowej wapniowej kamicy moczowej.
4445165 1974. Effects of hydrochlorothiazide on water, cation, and norepinephrine contents of cardiovascular tissues of renovascular hypertensive dogs.
4777585 1973. The effect of hydrochlorothiazide on water, cation and norepinephrine content of cardiovascular tissues of normotensive dogs.
5438927 1970. Magneziuria in hipertensiunea arteriala dupa administrarea de saluretice.
18270222 2008. Pseudoneuropathic CPPD arthropathy: magnesium matters.
3047887 1988. Effect of indapamide on serum and red cell cations, with and without magnesium supplementation, in subjects with mild hypertension.
3941959 1986. Effects of an acebutolol-hydrochlorothiazide combination on urinary solute excretion in healthy adults.
6387965 1984. Effects of hydrochlorothiazide plus sotalol on acute urinary electrolyte excretion in normal subjects.
7025258 1981. Antihypertensive and metabolic effects of a combination of hydrochlorothiazide and amiloride.
10546515 1999. Gitelman's syndrome: report of a 19-year old woman with intractable hypomagnesemia and hypokalemia, and a review of the syndrome.
2617153 1989. Effects of the thiazide diuretic bendroflumethiazide on salivary flow rate and composition.
6463598 1984. Metabolic effects of thiazide versus placebo in patients under long-term treatment for recurrent urolithiasis.
7323748 1981. Calcium and magnesium metabolism during long-term treatment with thiazides.
4838924 1974. The long-term effect of bendroflumethiazide on renal calcium and magnesium excretion and stone formation in patients with recurring renal stones.
6387895 1984. Biochemical studies in calcium oxalate stone formers, with special reference to the effects of thiazide treatment.
2609140 1989. Wirkung von Trichlormethiazid und Amilorid auf die zellulare Na+-, K+- und Mg2+-Konzentration.
1695392 1990. Magnesium deficiency in two hypertensive patient groups.
3526575 1986. Essential hypertension: new insights and controversies in treatment with diuretics.
10894026 2000. Kardiale Risiken der Hypokaliamie und Hypomagnesiamie.
5855992 1965. Action hypocalciurique du benzthiazide appreciee sur 50 cas de lithiase renale hypercalciurique. Etude conjointe de l'elimination phosphatee, magnesienne, uratique, et du comportement de l'acidite titrable et du pH urinaire.
13737578 1961. Effects of benzydroflumethiazide (Naturetin) on the renal excretion of calcium and magnesium by dogs.
8066894 1994. Peroralt magnesiumtilskud til patienter i diuretisk behandling--normalisering of magnesium, kalium og natrium, kalium-pumper i tvoerstribet muskulatur.
2711486 1989. Magnesium og langvarig diuretikabehandling.
969298 1976. [Comparative evaluation of diuretic effect of hypothiazide, furosemide and magnesium sulfate in the complex treatment of pregnant women with toxemia of the 2d half of pregnancy].
3962310 1986. Kaliumsparende Wirkung von Triamteren in einem Dreifachkombinationspraparat zur Therapie der Hypertonie.
5725146 1968. Der Finfluss von Hydrochlorthiazid auf einige Serumkationen und ihre Ausscheidung bei essentieller Hypertonie.

PubMed x

15242834 2004. Opening of mitochondrial KATP channels enhances cardioprotection through the modulation of mitochondrial matrix volume, calcium accumulation, and respiration.
12865255 2003. Altered expression of major renal Na transporters in rats with bilateral ureteral obstruction and release of obstruction.
12643408 2002. Diazoxide amelioration of myocardial injury and mitochondrial damage during cardiac surgery.
32306897 2020. Diazoxide affects mitochondrial bioenergetics by the opening of mKATP channel on submicromolar scale.
7437242 1980. Studies on the mechanism and characteristics of action of a uricosuric diuretic, indacrinone (MK-196).
5469617 1970. The effects of probenecid and thiazides and their combination on the urinary excretion of electrolytes and on acid-base equilibrium.
24944377 2003. Efficacy and tolerability of delapril plus indapamide versus lisinopril plus hydrochlorothiazide combination treatments in mild to moderate hypertension: a multicenter, randomized clinical study.
21468178 2009. Acquired gitelman syndrome.
15339977 2004. Altered renal distal tubule structure and renal Na(+) and Ca(2+) handling in a mouse model for Gitelman's syndrome.
28783044 2017. Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia.
1133175 1975. The acute effect of chlorothiazide on serum-ionized calcium. Evidence for a parathyroid hormone-dependent mechanism.
9382893 1997. Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor.
3758469 1986. Comparison of the diuretic effects of single dose frusemide/triamterene and hydrochlorothiazide/amiloride in healthy adults.
16914619 2006. Cyclothiazide prolongs low [Mg2+]-induced seizure-like events.
12562892 2003. Matrix volume measurements challenge the existence of diazoxide/glibencamide-sensitive KATP channels in rat mitochondria.
26751802 2016. Polymorphisms in the SLC12A3 Gene Encoding Sodium-Chloride Cotransporter are Associated with Hypertension: A Family-Based Study in the Mongolian Population.
12590198 2002. Novel NCCT gene mutations as a cause of Gitelman's syndrome and a systematic review of mutant and polymorphic NCCT alleles.
10652038 2000. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia.
3404813 1988. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria.
351268 1978. Prevention of calcium stones with thiazides.
11117978 2000. Images in clinical medicine. Trousseau's sign.
31181261 2019. Thiazide diuretics and risk of knee replacement surgery among patients with knee osteoarthritis: a general population-based cohort study.
18052684 2008. Importance of timing of magnesium administration in the isolated ischemic-reperfused rat heart: role of K(ATP) channels.
3521208 1986. Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene.
6963086 1982. Potassium and magnesium balance in thiazide-treated cardiac patients with special reference to diet.
83101 1979. Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment.
2309624 1990. Interaction of diuretics and electrolytes in congestive heart failure.
2353669 1990. Relation of cardiovascular disease to potassium and magnesium deficiencies.
2643289 1989. Electrolyte disarray and cardiovascular disease.
3524185 1986. Hypokalemia in thiazide-treated systemic hypertension.
3907323 1985. Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem.
3415812 1988. Effects of oral magnesium on blood pressure and red cell sodium transport in patients receiving long-term thiazide diuretics for hypertension.
3565424 1987. Magnesium deficiency: pathogenesis, prevalence, and clinical implications.
3565422 1987. Potassium/magnesium depletion in patients with cardiovascular disease.
2436474 1987. Magnesium depletion, diuretics, and arrhythmias.
14233692 1964. COMBINED TREATMENT OF ECLAMPSIA WITH HYPOTENSIVE DRUGS, MAGNESIUM SULFATE, AND SALURETICS.
1147045 1975. Interrelationship of chlorothiazide and parathyroid hormone: a micropuncture study.
32800318 2020. Fibrillation atriale et allongement du QT sur hypomagnesemie secondaire a un traitement par inhibiteur de la pompe a protons.
4766912 1973. Diuretic-hypotensive therapy and fetal prognosis in toxaemia of pregnancy. 1. Fetal prognosis in 705 selected cases.
2491733 1989. Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis.
4642739 1972. Hydrochlorothiazide effects on serum calcim and immunoreactive parathyroid hormone concentrations. Studies in normal subjects.
5448748 1970. Thiazide-induced rise in serum calcium and magnesium in patients on maintenance hemodialysis.
2596940 1989. Potassium restoration in hypertensive patients made hypokalemic by hydrochlorothiazide.
6684935 1983. Pharmakodynamik und Pharmakokinetik von Bemetizid im Vergleich zu Hydrochlorothiazid. Eine kontrollierte humanpharmakologische Studie der Akutwirkungen.
1932064 1991. Solubilization and partial purification of the thiazide diuretic receptor from rabbit renal cortex.
4027505 1985. Allopurinol treatment of renal calcium stone disease.
32710267 2020. Hypomagnesemia with Hypercalciuria Leading to Nephrocalcinosis, Amelogenesis Imperfecta, and Short Stature in a Child Carrying a Homozygous Deletion in the CLDN16 Gene.
14962487 2004. Diazoxide causes early activation of cardiac sarcolemmal KATP channels during metabolic inhibition by an indirect mechanism.
1728508 1992. Electrolyte abnormalities underlying lethal and ventricular arrhythmias.
5043786 1972. Enhancement of renal excretion of zinc by hydrochlorothiazide.
3581484 1987. Production and reversal of DOCA-salt hypertension in baboons.
2706807 1989. Effect of magnesium depletion and potassium depletion and chlorothiazide on intracellular pH in the rat, studied by 31P NMR.
1338305 1992. Action of diuretics at the cellular level.
5955334 1966. Treatment of severe preeclampsia and eclampsia.
466932 1979. Effect of thiazides on serum calcium.
17933337 2007. Involvement of SH-groups during interaction of diazoxide with the inner membrane of rat heart mitochondria.
1712714 1991. Effects of diuretics on outputs and flows of urine and urinary solutes in healthy subjects.
5501431 1970. Beitrage zur Prophylaxe und Behandlung des Leberkomas.
26121437 2015. NORMOMAGNESEMIC GITELMAN SYNDROME PATIENTS EXHIBIT A STRONGER REACTION TO THIAZIDE THAN HYPOMAGNESEMIC PATIENTS.
1486914 1992. Adverse reactions to diuretics.
8005195 1994. The saluretic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rate.
6734710 1984. Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function.
28806048 2017. Electrolytes: Calcium Disorders.
6662296 1983. Effects of selected therapeutic agents on urolithiasis induced by terephthalic acid in the male weanling Fischer 344 rat.
8199766 1994. Prevention of hypokalemia caused by diuretics.
12112667 2002. Identification of fifteen novel mutations in the SLC12A3 gene encoding the Na-Cl Co-transporter in Italian patients with Gitelman syndrome.
8206564 1994. Glucose and insulin levels during diuretic therapy in hypertensive men.
4077235 1985. Serum lipoproteins during treatment with the antihypertensive agent indapamide.
3440634 1987. Lack of effect of piretanide (a potassium-stable diuretic) on serum magnesium.
28835974 2017. Hyperkalzamische Krise und hypokalzamische Tetanie.
5567543 1971. The effect of hydrochlorothiazide administration on serum and urinary calcium in normal, hypoparathyroid and hyperparathyroid subjects. Studies on mechanisms.
16274367 2005. Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects.
8463545 1993. Magnesium and hypertension.
23735418 2013. Altered vascular structure and wave reflection in hypertensive women with low magnesium levels.
4044775 1985. Exaggerated natriuretic and calciuric responses to hydrochlorothiazide in renal hypercalciuria but not in absorptive hypercalciuria.
16370563 2005. Diagnosis of a case of Gitelman's syndrome based on renal clearance studies and gene analysis of a novel mutation of the thiazide-sensitive Na-Cl cotransporter.
22278145 2012. A comparison of the natriuretic and kaliuretic effects of cicletanine and hydrochlorothiazide in prehypertensive and hypertensive humans.
1316397 1992. Cardiotoxicity and diuretics: much speculation--little substance.
21062005 2010. Acetic acid derivatives of 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide as a novel class of potent aldose reductase inhibitors.
2447283 1987. Interaction of diazoxide, tolbutamide and ATP4- on nucleotide-dependent K+ channels in an insulin-secreting cell line.
2490542 1989. Monitoring the effect of triamterene and hydrochlorothiazide on dihydrofolate reductase activity using a new spectrophotometric method.
6429324 1984. The role of cilia and flagella in cell interactions.
4057368 1985. Graphic display of urinary risk factors for renal stone formation.
1979000 1990. Hypomagnesemia in chronic obstructive lung disease: effect of therapy.
4421549 1974. A critical survey of drugs used in the treatment of hypertensive crises of pregnancy.
10419549 1999. A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K(+) channels by K(+) channel openers.
7354777 1980. Responses to hydrochlorothiazide and acetazolamide in patients with calcium stones. Evidence suggesting a defect in renal tubular function.
16008036 2005. Van gen naar ziekte; mutaties in het SLC12A3-gen als oorzaak van het syndroom van Gitelman.
12584272 2003. Exclusion of mutations in FXYD2, CLDN16 and SLC12A3 in two families with primary renal Mg2+ loss.
2234498 1990. Potassium channel activators abolish excitotoxicity in cultured hippocampal pyramidal neurons.
15171343 2004. [Calcium, magnesium and potassium intake in hypertension].
33595712 2021. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
2534969 1989. "Chloride-shunt" syndrome: an overlooked cause of renal hypercalciuria.
2011469 1991. The hypocalciuric effect of thiazides: subcellular localization of the action.
4236484 1968. The effects of pharmacologic agents on myocardial sodium (Na+) and potassium (K+) stimulated ATPase.
575212 1979. Wplyw furosemidu kwasu etakrynowego, acetazolamidu i chlorotiazydu na nerkowe wydalanie sodu, wapnia, magnezu, fosforanow i wodoroweglanow u ludzi z prawidlowa.
1962853 1990. Wplyw hydrochlorotiazydu na metabolizm wapnia w pooperacyjnej niedoczynnosci tarczycy.
6634508 1983. Stezenie potasu, magnezu i cynku w surowicy krwi, w granulocytach i limfocytach u chorych na nadcisnienie tetnicze leczonych hydrochlorotiazydem.
693386 1978. W plyw hydrochlorotiazydu na parametry wapniowo-magnezowe u chorych z kamica nerkowa nawrotowa.
704435 1978. Wplyw hydrochlorotiazydu na wybrane parametry gospodarki wapniowo-magnezowej u chorych unieruchomionych.
20650971 2010. Gitelman syndrome: pathophysiological and clinical aspects.
14141268 1964. TERAPIA DELLA SINDROME DI MORGAGNI-ADAMS-STOKES.
3088739 1986. Effects of single doses of two antihypertensive rauwolfia-diuretic combinations on urinary excretion.
6356402 1983. Indapamide: a review.
6105720 1980. The management of hypertension in pregnancy: A review.
8140565 1993. Diuretiques, depletion potassique et hyperexcitabilite ventriculaire.
4715491 1973. Effect of diuretics on renal iodide excretion by humans.
18183543 2007. Influence of hydrochlorothiazide on urinary calcium oxalate relative supersaturation in healthy young adult female domestic shorthaired cats.
15641234 1999. Nove perspektivy liecby osteoporozy tiazidmi.

PMC

19759873 2009. The effects of diuretics on intracellular Ca2+ dynamics of arteriole smooth muscles as revealed by laser confocal microscopy.
33532188 2021. Discovery of novel diarylamides as orally active diuretics targeting urea transporters.
29188803 2018. Activation of human smooth muscle BK channels by hydrochlorothiazide requires cell integrity and the presence of BK beta1 subunit.
32603001 2021. Mechanisms coupling sodium and magnesium reabsorption in the distal convoluted tubule of the kidney.
27129733 2017. Role and mechanisms of regulation of the basolateral Kir 4.1/Kir 5.1K(+) channels in the distal tubules.
32147003 2020. The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?
29793662 2018. Magnesium Handling in the Kidney.
30139460 2018. Renal Tubular Acidosis: H(+)/Base and Ammonia Transport Abnormalities and Clinical Syndromes.
28140318 2016. Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.
29546166 2016. Magnesium: Nutrition and Homoeostasis.
27448942 2016. Effects of Potassium Magnesium Citrate Supplementation on 24-Hour Ambulatory Blood Pressure and Oxidative Stress Marker in Prehypertensive and Hypertensive Subjects.
21397062 2011. CNNM2, encoding a basolateral protein required for renal Mg2+ handling, is mutated in dominant hypomagnesemia.
14628289 2003. A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting.
18451809 2008. Action of thiazide on renal interstitial calcium.
21035933 2010. Tubular transport: core curriculum 2010.
21839714 2011. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
4691282 1973. Acute effect of prednisolone on renal handling of sodium.
31747317 2020. Cryo-EM structures of DrNKCC1 and hKCC1: a new milestone in the physiology of cation-chloride cotransporters.
32579473 2020. WNK3 and WNK4 exhibit opposite sensitivity with respect to cell volume and intracellular chloride concentration.
27170636 2016. With no lysine L-WNK1 isoforms are negative regulators of the K+-Cl- cotransporters.
27122160 2016. The Ste20 kinases SPAK and OSR1 travel between cells through exosomes.
23114965 2013. Effects of ACE inhibition and ANG II stimulation on renal Na-Cl cotransporter distribution, phosphorylation, and membrane complex properties.
23034389 2012. Calcium-binding protein 39 facilitates molecular interaction between Ste20p proline alanine-rich kinase and oxidative stress response 1 monomers.
33174766 2021. SARS-CoV-2: influence of phosphate and magnesium, moderated by vitamin D, on energy (ATP) metabolism and on severity of COVID-19.
32142358 2020. The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension.
22058154 2012. How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.
18586884 2008. Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT.
33719576 2021. Roles of WNK4 and SPAK in K(+)-mediated dephosphorylation of the NaCl cotransporter.
33682442 2021. Role of KLHL3 and dietary K(+) in regulating KS-WNK1 expression.
34029142 2021. Landscape of GPCR expression along the mouse nephron.
34151590 2021. Differential localization patterns of claudin 10, 16, and 19 in human, mouse, and rat renal tubular epithelia.
32715757 2020. Distal convoluted tubule Cl(-) concentration is modulated via K(+) channels and transporters.
32308018 2020. Epoxyeicosatrienoic acid metabolites inhibit Kir4.1/Kir5.1 in the distal convoluted tubule.
33135481 2020. NaCl cotransporter activity and Mg(2+) handling by the distal convoluted tubule.
31364380 2019. Mg(2+) restriction downregulates NCC through NEDD4-2 and prevents its activation by hypokalemia.
30539650 2019. "I don't get no respect": the role of chloride in acute kidney injury.
31215804 2019. Effects of reactive oxygen species on renal tubular transport.
30623725 2019. Adenine acts in the kidney as a signaling factor and causes salt- and water-losing nephropathy: early mechanism of adenine-induced renal injury.
29846116 2018. Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC.
29897283 2018. Kir5.1 regulates Nedd4-2-mediated ubiquitination of Kir4.1 in distal nephron.
28003191 2017. Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms.
28356287 2017. PGF2alpha regulates the basolateral K channels in the distal convoluted tubule.
26792067 2016. New perspective of ClC-Kb/2 Cl- channel physiology in the distal renal tubule.
27122539 2016. The expression, regulation, and function of Kir4.1 (Kcnj10) in the mammalian kidney.
26608788 2016. PTH modulation of NCC activity regulates TRPV5 Ca2+ reabsorption.
26632606 2016. Insulin and IGF-1 activate Kir4.1/5.1 channels in cortical collecting duct principal cells to control basolateral membrane voltage.
26582761 2016. The role of calbindin-D28k on renal calcium and magnesium handling during treatment with loop and thiazide diuretics.
27707706 2016. Solute transport and oxygen consumption along the nephrons: effects of Na+ transport inhibitors.
27009335 2016. Renal tubular SGK1 deficiency causes impaired K+ excretion via loss of regulation of NEDD4-2/WNK1 and ENaC.
25520012 2015. Acute effects of aldosterone on the epithelial Na channel in rat kidney.
24598799 2014. Increasing plasma [K+] by intravenous potassium infusion reduces NCC phosphorylation and drives kaliuresis and natriuresis.
24761002 2014. Modulation of NCC activity by low and high K(+) intake: insights into the signaling pathways involved.
24848496 2014. Effects of NKCC2 isoform regulation on NaCl transport in thick ascending limb and macula densa: a modeling study.
23785098 2013. AMPK couples plasma renin to cellular metabolism by phosphorylation of ACC1.
23054253 2013. Disease-causing R1185C mutation of WNK4 disrupts a regulatory mechanism involving calmodulin binding and SGK1 phosphorylation sites.
24133122 2013. Regulation of NKCC2 activity by inhibitory SPAK isoforms: KS-SPAK is a more potent inhibitor than SPAK2.
23698114 2013. Endothelin-1 inhibits sodium reabsorption by ET(A) and ET(B) receptors in the mouse cortical collecting duct.
23637202 2013. Cortical distal nephron Cl(-) transport in volume homeostasis and blood pressure regulation.
22791339 2012. Endotoxemia alters tight junction gene and protein expression in the kidney.
22791335 2012. Kidney-specific WNK1 inhibits sodium reabsorption in the cortical thick ascending limb.
22674028 2012. Membrane-associated aquaporin-1 facilitates osmotically driven water flux across the basolateral membrane of the thick ascending limb.
22338089 2012. Basolateral membrane K+ channels in renal epithelial cells.
22114204 2012. WNK4 inhibits NCC protein expression through MAPK ERK1/2 signaling pathway.
22647633 2012. Differential effects of extracellular ATP on chloride transport in cortical collecting duct cells.
22622459 2012. Tissue kallikrein activation of the epithelial Na channel.
21816753 2011. Role of NKCC in BK channel-mediated net K(+) secretion in the CCD.
21900458 2011. Molecular regulation of NKCC2 in the thick ascending limb.
21270092 2011. Recent advances in distal tubular potassium handling.
21209010 2011. Rare mutations in the human Na-K-Cl cotransporter (NKCC2) associated with lower blood pressure exhibit impaired processing and transport function.
19923405 2010. Physiology and pathophysiology of the calcium-sensing receptor in the kidney.
19474192 2009. The thiazide-sensitive Na+-Cl- cotransporter: molecular biology, functional properties, and regulation by WNKs.
19458126 2009. A comprehensive guide to the ROMK potassium channel: form and function in health and disease.
18579701 2008. Renal Na+-K+-Cl- cotransporter activity and vasopressin-induced trafficking are lipid raft-dependent.
18768590 2008. WNK3 positively regulates epithelial calcium channels TRPV5 and TRPV6 via a kinase-dependent pathway.
18550644 2008. Domains of WNK1 kinase in the regulation of ROMK1.
17494091 2007. Epoxyeicosatrienoic acids affect electrolyte transport in renal tubular epithelial cells: dependence on cyclooxygenase and cell polarity.
16774906 2006. Claudins 6, 9, and 13 are developmentally expressed renal tight junction proteins.
16106034 2005. Contribution of the basolateral isoform of the Na-K-2Cl- cotransporter (NKCC1/BSC2) to renin secretion.
24474103 2013. Treatment of superficial mycoses: review. Part II.
942168 1976. Magnesium metabolism: a brief review.
34164489 2021. Association of furosemide or hydrochlorothiazide use with risk of atrial fibrillation post pacemaker implantation among elderly patients.
25839058 2014. Role of Cellular Magnesium in Human Diseases.
27942049 2016. Potassium depletion stimulates Na-Cl cotransporter via phosphorylation and inactivation of the ubiquitin ligase Kelch-like 3.
22342722 2012. Disease-causing mutations in the acidic motif of WNK4 impair the sensitivity of WNK4 kinase to calcium ions.
18703016 2008. WNK4 regulates the secretory pathway via which TRPV5 is targeted to the plasma membrane.
24393035 2014. The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters.
23387299 2013. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
22032326 2012. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.
17341212 2007. Regulation of the renal-specific Na+-K+-2Cl- co-transporter NKCC2 by AMP-activated protein kinase (AMPK).
16669787 2006. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.
16083423 2005. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
14611643 2004. WNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (protein kinase B)/Akt substrate.
5807208 1969. The interaction of various inhibitors and stimuli of insulin release studied with rabbit pancreas in vitro.
26208601 2015. Domain-Swapping Switch Point in Ste20 Protein Kinase SPAK.
24877130 2014. The importance of the ionic product for water to understand the physiology of the acid-base balance in humans.
20655835 2010. Metabolic oscillations in pancreatic islets depend on the intracellular Ca2+ level but not Ca2+ oscillations.
30737304 2019. Metabolomic analysis reveals a protective effect of Fu-Fang-Jin-Qian-Chao herbal granules on oxalate-induced kidney injury.
23531202 2013. Impact of diuretic therapy-associated electrolyte disorders present on admission to the emergency department: a cross-sectional analysis.
28882112 2017. Identification of adenylyl cyclase isoforms mediating parathyroid hormone- and calcitonin-stimulated cyclic AMP accumulation in distal tubule cells.
28325719 2017. Near death by milk of magnesia.
34584906 2021. Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease.
328024 1977. Massive digoxin ingestion. Report of a case and review of currently available therapies.
14583761 2003. Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin.
10594466 1999. Effect of chronic magnesium supplementation on magnesium distribution in healthy volunteers evaluated by 31P-NMRS and ion selective electrodes.
8485017 1993. A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.
2271378 1990. Absence of magnesium sparing effect of a single dose of triamterene in combination with frusemide in healthy male adults.
27278329 2016. The function and regulation of acid-sensing ion channels (ASICs) and the epithelial Na(+) channel (ENaC): IUPHAR Review 19.
17965749 2008. Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems.
11564656 2001. Synthesis and characterization of a quinolinonic compound activating ATP-sensitive K(+) channels in endocrine and smooth muscle tissues.
8075882 1994. Improvement of cardiovascular effects of metoprolol by replacement of common salt with a potassium- and magnesium-enriched salt alternative.
1111794 1975. Clinicopathological conference. A case of hypoaldosteronism.
5071700 1972. Magnesium deficiency in patients on long-term diuretic therapy for heart failure.
2450616 1988. Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics.
6423182 1984. Fasting plasma magnesium concentrations and glucose disposal in diabetes.
6407598 1983. Effect of magnesium on blood pressure.
6812785 1982. Diuretic-associated hypomagnesaemia.
6291694 1982. Magnesium deficiency and diuretics.
8754704 1996. Muscle cramps and magnesium deficiency: case reports.
6713257 1984. Effects of thyroid status on renal calcium and magnesium handling.
6418367 1984. A clinical approach to common electrolyte problems: 3. Hypophosphatemia.
6344969 1983. A clinical approach to common electrolyte problems: 2. Potassium imbalances.
343905 1978. Role of the adrenal cortex and sodium in the pathogenesis of human hypertension.
5469617 1970. The effects of probenecid and thiazides and their combination on the urinary excretion of electrolytes and on acid-base equilibrium.
5344992 1969. Diuretics in cardiac edema--1969.
14123666 1964. EFFECT OF HYDROCHLOROTHIAZIDE ON SERUM AND URINARY CALCIUM AND URINARY CITRATE.
13832434 1960. A low sodium, high water, high potassium regimen in the successful management of some cardiovascular diseases. Preliminary clinical report.
13815733 1959. Primary aldosteronism. A review of medical literature from 1955 to June 1958.
28730291 2017. Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management.
32378135 2020. Proposal for New Classification and Practical Use of Diuretics According to Their Effects on the Serum Chloride Concentration: Rationale Based on the "Chloride Theory".
32185580 2020. Effects of Sodium-Glucose Co-transporter 2 Inhibition with Empaglifozin on Renal Structure and Function in Non-diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction.
34012542 2021. Chronic obstructive pulmonary disease: Is serum magnesium level a risk factor for its acute exacerbation?
21907141 2011. A SPAK isoform switch modulates renal salt transport and blood pressure.
31561038 2020. Regulation of CFTR Bicarbonate Channel Activity by WNK1: Implications for Pancreatitis and CFTR-Related Disorders.
22960604 2012. Germinal center kinases in immune regulation.
33440155 2021. Magnesium and Calcium Homeostasis Depend on KCTD1 Function in the Distal Nephron.
29069584 2017. Dendritic Cell Amiloride-Sensitive Channels Mediate Sodium-Induced Inflammation and Hypertension.
34204757 2021. With-No-Lysine Kinase 1 (WNK1) Augments TRPV4 Function in the Aldosterone-Sensitive Distal Nephron.
32659887 2020. Calcium-Sensing Receptor and Regulation of WNK Kinases in the Kidney.
33291725 2020. TRPM Channels in Human Diseases.
29450857 2018. Hypokalemia associated with pseudo-Cushing's syndrome and magnesium deficiency induced by chronic alcohol abuse.
30264650 2018. Role of the alternative splice variant of NCC in blood pressure control.
32065054 2020. T-Cell-Derived miRNA-214 Mediates Perivascular Fibrosis in Hypertension.
22811560 2012. Mitochondrial ROMK channel is a molecular component of mitoK(ATP).
16020754 2005. Mitochondria-derived reactive oxygen species dilate cerebral arteries by activating Ca2+ sparks.
32158059 2020. Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.
18568054 2003. Magnesium metabolism and its disorders.
17847041 2007. Hyponatremia and vasopressin antagonism in congestive heart failure.
33398605 2021. Hypokalemia in Patients with COVID-19.
28289910 2017. Acid-base disturbances in nephrotic syndrome: analysis using the CO2/HCO3 method (traditional Boston model) and the physicochemical method (Stewart model).
30948456 2019. Rate of Correction of Hypernatremia and Health Outcomes in Critically Ill Patients.
30728169 2019. Hypernatremia.
30232135 2018. Inching toward a Greater Understanding of Genetic Hypercalciuria: The Role of Claudins.
24721891 2015. Regulation of Potassium Homeostasis.
25287933 2015. Renal control of calcium, phosphate, and magnesium homeostasis.
25318757 2014. Thick ascending limb of the loop of Henle.
24789550 2014. Homeostasis, the milieu interieur, and the wisdom of the nephron.
24855283 2014. Distal convoluted tubule.
21233458 2011. Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent.
33123363 2020. Regulation of urinary calcium excretion by vasopressin.
33391739 2020. Dietary potassium and the kidney: lifesaving physiology.
26613020 2015. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics.
25852890 2014. Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis.
25852875 2014. Hypomagnesemia and hypokalemia: a successful oral therapeutic approach after 16 years of potassium and magnesium intravenous replacement therapy.
26069819 2012. Magnesium basics.
26069817 2012. Regulation of magnesium balance: lessons learned from human genetic disease.
26069797 2012. Increased expression of renal TRPM6 compensates for Mg(2+) wasting during furosemide treatment.
14703029 2003. Clinical use of diuretics.
33061673 2020. Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial Study.
31403094 2019. A Case of Thiazide-induced Hypokalemic Paralysis.
29352074 2018. Aldosterone, SGK1, and ion channels in the kidney.
12668546 2003. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state.
26890278 2016. Amiloride Analogs as ASIC1a Inhibitors.
27900370 2016. A patient with multisystem dysfunction carries a truncation mutation in human SLC12A2, the gene encoding the Na-K-2Cl cotransporter, NKCC1.
33597714 2021. The structural basis of function and regulation of neuronal cotransporters NKCC1 and KCC2.
25589264 2015. Distal convoluted tubule.
25428859 2014. Molecular mechanisms and regulation of urinary acidification.
25428855 2014. Cation-coupled bicarbonate transporters.
23728973 2012. Peripheral chemoreceptors: function and plasticity of the carotid body.
23227301 2012. Regulation of transport in the connecting tubule and cortical collecting duct.
33732556 2021. Calcium-Alkali Syndrome: Historical Review, Pathophysiology and Post-Modern Update.
27306796 2016. Basolateral Kir4.1 activity in the distal convoluted tubule regulates K secretion by determining NaCl cotransporter activity.
20601877 2010. Regulation and function of potassium channels in aldosterone-sensitive distal nephron.
19584721 2009. The physiological impact of the serum and glucocorticoid-inducible kinase SGK1.
27906866 2017. Inherited and acquired disorders of magnesium homeostasis.
32682281 2020. Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance.
31196609 2019. Ion channels and transporters in diabetic kidney disease.
30243436 2018. Water Homeostasis and Cell Volume Maintenance and Regulation.
31109940 2019. Sodium-Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research.
22498805 2012. Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease.
28197834 2017. Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials.
23920220 2013. Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways.
30720256 1999. Disorders of Magnesium Metabolism.
24459527 2008. Magnesium metabolism.
24434184 2014. FGF23 promotes renal calcium reabsorption through the TRPV5 channel.
22373575 2012. Claudin-14 regulates renal Ca(+)(+) transport in response to CaSR signalling via a novel microRNA pathway.
21423148 2011. MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases.
17006539 2006. Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5.
16763551 2006. Calbindin-D28K dynamically controls TRPV5-mediated Ca2+ transport.
12881418 2003. N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits.
9135131 1997. The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide.
26286618 2015. Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia.
24797667 2014. FGF23 regulates renal sodium handling and blood pressure.
20091762 2010. Role of the WNK-activated SPAK kinase in regulating blood pressure.
26273099 2015. Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6.
19494665 2009. Disorders of phosphate homeostasis and tissue mineralisation.
34277971 2021. Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program.
27252863 2016. The McKittrick-Wheelock syndrome: a rare cause of curable diabetes.
11888758 2002. Selective opening of mitochondrial ATP-sensitive potassium channels during surgically induced myocardial ischemia decreases necrosis and apoptosis.
32931782 2020. Possibility of magnesium supplementation for supportive treatment in patients with COVID-19.
29657876 2018. Magnesium disorders can cause calcium pyrophosphate deposition disease: A case report and literature review.
28694751 2017. The role of magnesium sulfate in the intensive care unit.
22405999 2012. WNK kinases and the kidney.
34464223 2021. Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease.
19764891 2009. Targeting SGK1 in diabetes.
32799394 2020. NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease.
30252533 2019. Urinary concentrating defect in mice lacking Epac1 or Epac2.
28778975 2017. EHD4 is a novel regulator of urinary water homeostasis.
24843071 2014. Diuresis and reduced urinary osmolality in rats produced by small-molecule UT-A-selective urea transport inhibitors.
28718502 2017. Chansporter complexes in cell signaling.
30766152 2016. Proton Pump Inhibitor-Associated Hypomagnesemia: A Retrospective Case-Control Study.
33282857 2020. The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities.
25653592 2014. Molecular and evolutionary insights into the structural organization of cation chloride cotransporters.
32509580 2020. Electrolyte Disorders Induced by Antineoplastic Drugs.
29686978 2018. Novel Aspects of Renal Magnesium Homeostasis.
33959029 2021. The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19.
31543812 2019. Mechanism of Thiazide Diuretic Arterial Pressure Reduction: The Search Continues.
33716756 2020. Sodium Transporters in Human Health and Disease.
33192599 2020. Physiological Processes Modulated by the Chloride-Sensitive WNK-SPAK/OSR1 Kinase Signaling Pathway and the Cation-Coupled Chloride Cotransporters.
32547422 2020. NBCe2 (Slc4a5) Is Expressed in the Renal Connecting Tubules and Cortical Collecting Ducts and Mediates Base Extrusion.
25138239 2015. Hypomagnesaemia associated with long-term use of proton pump inhibitors.
34068220 2021. The Molecular Basis of Calcium and Phosphorus Inherited Metabolic Disorders.
32164158 2020. Claudins in Renal Physiology and Pathology.
680596 1978. Changes in the electrolyte content of leucocytes at different clinical stages of cirrhosis.
604188 1977. Potassium and magnesium depletion in patients with cirrhosis on maintenance diuretic regimens.
19639291 2009. Adenosine receptors and the kidney.
15367532 2004. Aldosterone blockade in cardiovascular disease.
12639869 2003. Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation.
25820346 2015. Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications.
25994507 2015. Critical role of the SPAK protein kinase CCT domain in controlling blood pressure.
21131289 2011. Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models.
21814209 2011. The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.
31865783 2020. Inhibition of AT2R and Bradykinin Type II Receptor (BK2R) Compromises High K(+) Intake-Induced Renal K(+) Excretion.
30571558 2019. Norepinephrine-Induced Stimulation of Kir4.1/Kir5.1 Is Required for the Activation of NaCl Transporter in Distal Convoluted Tubule.
29712740 2018. Beneficial Effects of High Potassium: Contribution of Renal Basolateral K(+) Channels.
29915013 2018. Bradykinin Stimulates Renal Na(+) and K(+) Excretion by Inhibiting the K(+) Channel (Kir4.1) in the Distal Convoluted Tubule.
19564550 2009. Thiazide effects and adverse effects: insights from molecular genetics.
18981326 2008. Changes in serum potassium mediate thiazide-induced diabetes.
29992053 2018. Beneficial Role of Mg(2+) in Prevention and Treatment of Hypertension.
34768805 2021. Anti-Inflammatory Activities of Captopril and Diuretics on Macrophage Activity in Mouse Humoral Immune Response.
33672238 2021. Differential Effects of STCH and Stress-Inducible Hsp70 on the Stability and Maturation of NKCC2.
32992944 2020. A Review of the Action of Magnesium on Several Processes Involved in the Modulation of Hematopoiesis.
33105763 2020. Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection.
32481620 2020. TRPV4: A Physio and Pathophysiologically Significant Ion Channel.
31671507 2019. A Novel Claudinopathy Based on Claudin-10 Mutations.
30889804 2019. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling.
31450703 2019. ERK1,2 Signalling Pathway along the Nephron and Its Role in Acid-base and Electrolytes Balance.
29891771 2018. Role of Magnesium Deficiency in Promoting Atherosclerosis, Endothelial Dysfunction, and Arterial Stiffening as Risk Factors for Hypertension.
27213360 2016. Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules.
26294976 2015. Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome.
29497325 2018. The importance of the thick ascending limb of Henle's loop in renal physiology and pathophysiology.
24966690 2014. Hypomagnesemia: a clinical perspective.
34729138 2021. Comparison of Sevelamer and Calcium Carbonate in Prevention of Hypomagnesemia in Hemodialysis Patients.
32952944 2020. Magnesium supplementation enhances insulin sensitivity and decreases insulin resistance in diabetic rats.
32054691 2020. Aldosterone Regulates Pendrin and Epithelial Sodium Channel Activity through Intercalated Cell Mineralocorticoid Receptor-Dependent and -Independent Mechanisms over a Wide Range in Serum Potassium.
32295826 2020. Renal Tubule Nedd4-2 Deficiency Stimulates Kir4.1/Kir5.1 and Thiazide-Sensitive NaCl Cotransporter in Distal Convoluted Tubule.
30988011 2019. Fluconazole Increases Osmotic Water Transport in Renal Collecting Duct through Effects on Aquaporin-2 Trafficking.
30902838 2019. Protein Phosphatase 1 Inhibitor-1 Mediates the cAMP-Dependent Stimulation of the Renal NaCl Cotransporter.
30559144 2019. Kir4.1/Kir5.1 Activity Is Essential for Dietary Sodium Intake-Induced Modulation of Na-Cl Cotransporter.
31239388 2019. Deletion of Kir5.1 Impairs Renal Ability to Excrete Potassium during Increased Dietary Potassium Intake.
30301860 2018. Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.
29848507 2018. The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway.
29093028 2018. Genome-Wide Meta-Analysis Unravels Interactions between Magnesium Homeostasis and Metabolic Phenotypes.
28052988 2017. Potassium Sensing by Renal Distal Tubules Requires Kir4.1.
27335120 2017. The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron.
25967121 2016. Calcineurin and Sorting-Related Receptor with A-Type Repeats Interact to Regulate the Renal Na(+)-K(+)-2Cl(-) Cotransporter.
25848073 2015. Caveolin-1 Deficiency Inhibits the Basolateral K+ Channels in the Distal Convoluted Tubule and Impairs Renal K+ and Mg2+ Transport.
25071082 2015. Epigenetic regulation of microRNAs controlling CLDN14 expression as a mechanism for renal calcium handling.
25377078 2015. Discovery of Novel SPAK Inhibitors That Block WNK Kinase Signaling to Cation Chloride Transporters.
24948743 2015. Claudins and the kidney.
21852580 2011. Nedd4-2 modulates renal Na+-Cl- cotransporter via the aldosterone-SGK1-Nedd4-2 pathway.
21355052 2011. Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1/SGK1-dependent phosphorylation of WNK1.
21164023 2011. gamma-Adducin stimulates the thiazide-sensitive NaCl cotransporter.
21436285 2011. The WNK kinase network regulating sodium, potassium, and blood pressure.
20966128 2010. Pendrin modulates ENaC function by changing luminal HCO3-.
20813865 2010. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction.
19423690 2009. Parathyroid hormone activates TRPV5 via PKA-dependent phosphorylation.
18562569 2008. Molecular determinants of magnesium homeostasis: insights from human disease.
33785360 2021. A key role for the transporter OAT1 in systemic lipid metabolism.
33548225 2021. Binding of calcium and magnesium to human cardiac troponin C.
33524393 2021. Angiotensin II increases activity of the ClC-K2 Cl(-) channel in collecting duct intercalated cells by stimulating production of reactive oxygen species.
34174287 2021. High dietary potassium causes ubiquitin-dependent degradation of the kidney sodium-chloride cotransporter.
32079677 2020. Paraoxonase 3 functions as a chaperone to decrease functional expression of the epithelial sodium channel.
29921588 2018. C-terminally truncated, kidney-specific variants of the WNK4 kinase lack several sites that regulate its activity.
27440044 2016. An Organic Anion Transporter 1 (OAT1)-centered Metabolic Network.
27466368 2016. Aldosterone Upregulates Transient Receptor Potential Melastatin 7 (TRPM7).
27551042 2016. Vesicle-associated Membrane Protein 3 (VAMP3) Mediates Constitutive Trafficking of the Renal Co-transporter NKCC2 in Thick Ascending Limbs: ROLE IN RENAL FUNCTION AND BLOOD PRESSURE.
26721884 2016. OS9 Protein Interacts with Na-K-2Cl Co-transporter (NKCC2) and Targets Its Immature Form for the Endoplasmic Reticulum-associated Degradation Pathway.
25086033 2014. Hypotonicity stimulates potassium flux through the WNK-SPAK/OSR1 kinase cascade and the Ncc69 sodium-potassium-2-chloride cotransporter in the Drosophila renal tubule.
25164821 2014. Short forms of Ste20-related proline/alanine-rich kinase (SPAK) in the kidney are created by aspartyl aminopeptidase (Dnpep)-mediated proteolytic cleavage.
24668812 2014. Phosphorylation decreases ubiquitylation of the thiazide-sensitive cotransporter NCC and subsequent clathrin-mediated endocytosis.
24828496 2014. beta1-Adrenergic receptor signaling activates the epithelial calcium channel, transient receptor potential vanilloid type 5 (TRPV5), via the protein kinase A pathway.
24811174 2014. A novel Ste20-related proline/alanine-rich kinase (SPAK)-independent pathway involving calcium-binding protein 39 (Cab39) and serine threonine kinase with no lysine member 4 (WNK4) in the activation of Na-K-Cl cotransporters.
24619423 2014. Reactive oxygen species, AMP-activated protein kinase, and the transcription cofactor p300 regulate alpha-tubulin acetyltransferase-1 (alphaTAT-1/MEC-17)-dependent microtubule hyperacetylation during cell stress.
23965991 2013. Recruitment of a cytoplasmic chaperone relay by the A2A adenosine receptor.
23970553 2013. The epithelial calcium channel TRPV5 is regulated differentially by klotho and sialidase.
23482560 2013. Hsp70 and Hsp90 multichaperone complexes sequentially regulate thiazide-sensitive cotransporter endoplasmic reticulum-associated degradation and biogenesis.
23255597 2013. The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel.
23430254 2013. Renal proteinase-activated receptor 2, a new actor in the control of blood pressure and plasma potassium level.
22989884 2012. Interactions with WNK (with no lysine) family members regulate oxidative stress response 1 and ion co-transporter activity.
22977238 2012. Dynamin2, clathrin, and lipid rafts mediate endocytosis of the apical Na/K/2Cl cotransporter NKCC2 in thick ascending limbs.
22977235 2012. SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner.
22399287 2012. Membrane topology and intracellular processing of cyclin M2 (CNNM2).
22027832 2011. The thiazide-sensitive NaCl cotransporter is targeted for chaperone-dependent endoplasmic reticulum-associated degradation.
21737451 2011. Activation of the bumetanide-sensitive Na+,K+,2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner.
19880514 2010. Increased potassium conductance of brain mitochondria induces resistance to permeability transition by enhancing matrix volume.
18550547 2008. PKCdelta acts upstream of SPAK in the activation of NKCC1 by hyperosmotic stress in human airway epithelial cells.
17190791 2007. Regulation of activity and localization of the WNK1 protein kinase by hyperosmotic stress.
31472005 2019. Dent disease: A window into calcium and phosphate transport.
32776569 2021. Molecular characteristics and physiological roles of Na(+) -K(+) -Cl(-) cotransporter 2.
21321328 2011. Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways.
32322899 2020. Hypoparathyroidism.
22392950 2012. Approach to the hypophosphatemic patient.
25415435 2015. mTORC2 regulates renal tubule sodium uptake by promoting ENaC activity.
23348737 2013. Renal tubular NEDD4-2 deficiency causes NCC-mediated salt-dependent hypertension.
22886306 2012. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor.
19307729 2009. A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia.
17975670 2007. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex.
17671655 2007. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia.
17671646 2007. When EGF is offside, magnesium is wasted.
17380208 2007. Intersectin links WNK kinases to endocytosis of ROMK1.
15902302 2005. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia.
12671053 2003. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
9486975 1998. Potassium depletion downregulates chloride-absorbing transporters in rat kidney.
7989584 1994. Activation of potassium channels contributes to hypoxic injury in proximal tubules.
1522230 1992. On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells.
1522228 1992. Intracellular ATP can regulate afferent arteriolar tone via ATP-sensitive K+ channels in the rabbit.
1322939 1992. Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells.
3366902 1988. Bicarbonate absorption stimulates active calcium absorption in the rat proximal tubule.
2841360 1988. Site and mechanism of action of trichlormethiazide in rabbit distal nephron segments perfused in vitro.
34768354 2021. Old and New Calcineurin Inhibitors in Lupus Nephritis.
33804573 2021. Focus on the Possible Role of Dietary Sodium, Potassium, Phosphate, Magnesium, and Calcium on CKD Progression.
31198735 2019. Association of serum magnesium with type 2 diabetes mellitus and diabetic retinopathy.
30002162 2018. Biaryl sulfonamide motifs up- or down-regulate ion channel activity by activating voltage sensors.
18504317 2008. Surface expression of epithelial Na channel protein in rat kidney.
10532965 1999. A mutation linked with Bartter's syndrome locks Kir 1.1a (ROMK1) channels in a closed state.
9806964 1998. Mutagenic mapping of the Na-K-Cl cotransporter for domains involved in ion transport and bumetanide binding.
9417141 1998. Properties of an inwardly rectifying ATP-sensitive K+ channel in the basolateral membrane of renal proximal tubule.
6502133 1984. Active ion transport in the renal proximal tubule. I. Transport and metabolic studies.
31296230 2019. K(+)-Cl(-) cotransporter 1 (KCC1): a housekeeping membrane protein that plays key supplemental roles in hematopoietic and cancer cells.
29610664 2018. Hypomagnesemia in critically ill patients.
19194547 2009. Effects of thiazide on the expression of TRPV5, calbindin-D28K, and sodium transporters in hypercalciuric rats.
15978901 2005. Mitochondrial K(ATP) channels in cell survival and death.
27246103 2016. The Sur1-Trpm4 channel regulates NOS2 transcription in TLR4-activated microglia.
31093455 2019. Evaluation and Treatment of Alkalosis in Children.
23118702 2004. The ABC's of Acid-Base Balance.
27068441 2016. SPAK and OSR1 play essential roles in potassium homeostasis through actions on the distal convoluted tubule.
17673510 2007. SLC26A9 is a Cl(-) channel regulated by the WNK kinases.
34166227 2021. A variant of ASIC2 mediates sodium retention in nephrotic syndrome.
31217358 2019. Development of a 2-dimensional atlas of the human kidney with imaging mass cytometry.
28931751 2017. Essential role of Kir5.1 channels in renal salt handling and blood pressure control.
29263298 2017. Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects.
28232934 2017. Disorders of Acid-Base Balance: New Perspectives.
29344508 2017. Acid-Base and Electrolyte Disorders in Patients with and without Chronic Kidney Disease: An Update.
29344503 2017. Genetics of Magnesium Disorders.
27536695 2016. Potassium: From Physiology to Clinical Implications.
28094030 2017. Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron.
27206969 2016. beta3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function.
26422504 2016. Unique chloride-sensing properties of WNK4 permit the distal nephron to modulate potassium homeostasis.
22278018 2012. Tubular cell dedifferentiation and peritubular inflammation are coupled by the transcription regulator Id1 in renal fibrogenesis.
34013099 2021. Use of Urine Electrolytes and Urine Osmolality in the Clinical Diagnosis of Fluid, Electrolytes, and Acid-Base Disorders.
29142966 2017. Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial.
26484029 2015. Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention.
24856029 2014. Rare inherited kidney diseases: challenges, opportunities, and perspectives.
30544795 2018. Spirulina maxima Decreases Endothelial Damage and Oxidative Stress Indicators in Patients with Systemic Arterial Hypertension: Results from Exploratory Controlled Clinical Trial.
29315692 2018. Comprehensive review of cardiovascular toxicity of drugs and related agents.
30987399 2019. Magnesium: The Forgotten Electrolyte-A Review on Hypomagnesemia.
31305454 2019. Gitelman's syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration: A case report.
19851835 2010. Opening of the mitoKATP channel and decoupling of mitochondrial complex II and III contribute to the suppression of myocardial reperfusion hyperoxygenation.
28052936 2017. KLHL3 Knockout Mice Reveal the Physiological Role of KLHL3 and the Pathophysiology of Pseudohypoaldosteronism Type II Caused by Mutant KLHL3.
20926757 2011. Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel.
18511652 2008. Sulfonylurea receptor-dependent and -independent pathways mediate vasodilation induced by ATP-sensitive K+ channel openers.
27440992 2016. Mechanism of the anticataract effect of liposomal MgT in galactose-fed rats.
34771058 2021. Metals and Metal-Nanoparticles in Human Pathologies: From Exposure to Therapy.
30959950 2019. Serum iron, Magnesium, Copper, and Manganese Levels in Alcoholism: A Systematic Review.
34140503 2021. Importance of the renal ion channel TRPM6 in the circadian secretion of renin to raise blood pressure.
32081947 2020. Structure of the human cation-chloride cotransporter NKCC1 determined by single-particle electron cryo-microscopy.
32868758 2020. Inherited salt-losing tubulopathies are associated with immunodeficiency due to impaired IL-17 responses.
31727896 2019. Elevated aldosterone and blood pressure in a mouse model of familial hyperaldosteronism with ClC-2 mutation.
26787103 2016. Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via Lipocalin 2.
26099046 2015. Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter.
26804019 2016. Mitochondrial dysfunction in inherited renal disease and acute kidney injury.
26334088 2015. The elementome of calcium-based urinary stones and its role in urolithiasis.
31435016 2019. Identification of an ATP-sensitive potassium channel in mitochondria.
31367042 2019. Structure and mechanism of the cation-chloride cotransporter NKCC1.
33097957 2021. Mutations in transcription factor CP2-like 1 may cause a novel syndrome with distal renal tubulopathy in humans.
29077944 2018. Association of serum magnesium with all-cause mortality in patients with and without chronic kidney disease in the Dallas Heart Study.
25281699 2015. The multiple roles of pendrin in the kidney.
25142949 2014. Proton-pump inhibitor use is associated with lower urinary magnesium excretion.
34202561 2021. Magnesium Deficiency Alters Expression of Genes Critical for Muscle Magnesium Homeostasis and Physiology in Mice.
33499378 2021. Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes.
33435187 2021. Effectively Prescribing Oral Magnesium Therapy for Hypertension: A Categorized Systematic Review of 49 Clinical Trials.
30241394 2018. Sodium Citrate Increases Expression and Flux of Mg(2+) Transport Carriers Mediated by Activation of MEK/ERK/c-Fos Pathway in Renal Tubular Epithelial Cells.
30200431 2018. Challenges in the Diagnosis of Magnesium Status.
29738504 2018. Changes of Blood Pressure and Hemodynamic Parameters after Oral Magnesium Supplementation in Patients with Essential Hypertension-An Intervention Study.
28178182 2017. Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.
24288027 2013. Calcium-alkali syndrome in the modern era.
26788202 2015. Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature.
29387426 2018. Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.
34733373 2021. Association between Hypomagnesemia, COVID-19, Respiratory Tract and Lung Disease.
24757368 2014. Hypertension: is it time to replace drugs with nutrition and nutraceuticals?
22593782 2012. Blood Magnesium levels in migraineurs within and between the headache attacks: a case control study.
27234911 2017. Genetic causes of hypomagnesemia, a clinical overview.
24253590 2015. Developmental changes in renal tubular transport-an overview.
21365189 2011. Claudins in renal physiology and disease.
22543357 2012. The second sodium pump: from the function to the gene.
18982348 2009. Thick ascending limb: the Na(+):K (+):2Cl (-) co-transporter, NKCC2, and the calcium-sensing receptor, CaSR.
18752000 2009. Micropuncturing the nephron.
31015873 2019. Efficacy and safety of the pharmacotherapy used in the management of hyperkalemia: a systematic review.
34208285 2021. Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease.
34198801 2021. Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review.
28230738 2017. Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target.
23788015 2013. PharmGKB summary: Diuretics pathway, pharmacodynamics.
34278747 2021. An overview of diagnosis and management of drug-induced hypomagnesemia.
32144120 2020. Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease.
33275999 2021. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
31861770 2019. A Quantitative and Narrative Evaluation of Goodman and Gilman's Pharmacological Basis of Therapeutics.
30849009 2019. Genetic and genomic evidence for an important role of the Na(+)/H(+) exchanger 3 in blood pressure regulation and angiotensin II-induced hypertension.
28389525 2017. Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.
26242933 2015. Role of the Na+/H+ exchanger 3 in angiotensin II-induced hypertension.
22805345 2012. Mitochondrial proteomic analysis reveals deficiencies in oxygen utilization in medullary thick ascending limb of Henle in the Dahl salt-sensitive rat.
17956998 2008. Transcriptional profiling of native inner medullary collecting duct cells from rat kidney.
34665521 2021. Role of collecting duct principal cell NOS1beta in sodium and potassium homeostasis.
30175537 2018. Renal Mg handling, FXYD2 and the central role of the Na,K-ATPase.
29038354 2017. Association of urinary citrate excretion, pH, and net gastrointestinal alkali absorption with diet, diuretic use, and blood glucose concentration.
25472608 2014. Paradoxical activation of the sodium chloride cotransporter (NCC) without hypertension in kidney deficient in a regulatory subunit of Na,K-ATPase, FXYD2.
32347156 2020. The Renal Physiology of Pendrin-Positive Intercalated Cells.
31437091 2020. Extracellular Nucleotides and P2 Receptors in Renal Function.
30354966 2019. Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.
28931564 2017. Towards Precision Medicine for Hypertension: A Review of Genomic, Epigenomic, and Microbiomic Effects on Blood Pressure in Experimental Rat Models and Humans.
25540142 2015. Molecular aspects of structure, gating, and physiology of pH-sensitive background K2P and Kir K+-transport channels.
25540139 2015. The organic anion transporter (OAT) family: a systems biology perspective.
25834230 2015. Renal autoregulation in health and disease.
23589833 2013. The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.
23589827 2013. Claudins and the modulation of tight junction permeability.
23073627 2012. Molecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport.
15618483 2005. Molecular diversity and regulation of renal potassium channels.
28700713 2017. Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome.
28493961 2017. Aldosterone signaling regulates the over-expression of claudin-4 and -8 at the distal nephron from type 1 diabetic rats.
27213818 2016. Spilanthol from Acmella Oleracea Lowers the Intracellular Levels of cAMP Impairing NKCC2 Phosphorylation and Water Channel AQP2 Membrane Expression in Mouse Kidney.
26540196 2015. Antagonistic Regulation of Parvalbumin Expression and Mitochondrial Calcium Handling Capacity in Renal Epithelial Cells.
25029519 2014. Empiric potassium supplementation and increased survival in users of loop diuretics.

24762817 2014. Emerging role of the calcium-activated, small conductance, SK3 K+ channel in distal tubule function: regulation by TRPV4.
24260196 2013. Potentiation of the effect of thiazide derivatives by carbonic anhydrase inhibitors: molecular mechanisms and potential clinical implications.
23874973 2013. Emerging role of calcium-activated potassium channel in the regulation of cell viability following potassium ions challenge in HEK293 cells and pharmacological modulation.
23717684 2013. Differences in the signaling pathways of alpha(1A)- and alpha(1B)-adrenoceptors are related to different endosomal targeting.
23383183 2013. Autosomal dominant hypercalciuria in a mouse model due to a mutation of the epithelial calcium channel, TRPV5.
23383138 2013. Regulation of two renal chloride transporters, AE1 and pendrin, by electrolytes and aldosterone.
23301036 2013. Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
22701621 2012. Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation.
19011682 2008. Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension.
18486714 2008. Disorders involving calcium, phosphorus, and magnesium.
31488724 2019. Phosphorylated claudin-16 interacts with Trpv5 and regulates transcellular calcium transport in the kidney.
30765526 2019. WNK4 kinase is a physiological intracellular chloride sensor.
28096417 2017. Phosphorylation by PKC and PKA regulate the kinase activity and downstream signaling of WNK4.
28373577 2017. Parathyroid hormone controls paracellular Ca(2+) transport in the thick ascending limb by regulating the tight-junction protein Claudin14.
25831548 2015. KLHL3 regulates paracellular chloride transport in the kidney by ubiquitination of claudin-8.
25157135 2014. The Cap1-claudin-4 regulatory pathway is important for renal chloride reabsorption and blood pressure regulation.
25313067 2014. Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation.
24958889 2014. mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress.
25071208 2014. KCNJ10 determines the expression of the apical Na-Cl cotransporter (NCC) in the early distal convoluted tubule (DCT1).
22550170 2012. Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process.
22891322 2012. Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs paracellular sodium permeability and leads to hypermagnesemia and nephrocalcinosis.
21972418 2011. Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome.
20921420 2010. Claudin-4 forms paracellular chloride channel in the kidney and requires claudin-8 for tight junction localization.
20651251 2010. KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function.
19289823 2009. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10.
18550832 2008. Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases.
17804801 2007. Renal expression of parvalbumin is critical for NaCl handling and response to diuretics.
16428287 2006. Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms.
16006511 2005. WNK1 activates SGK1 to regulate the epithelial sodium channel.
15070779 2004. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins.
14769928 2004. WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia.
15583131 2004. The kidney-specific WNK1 isoform is induced by aldosterone and stimulates epithelial sodium channel-mediated Na+ transport.
8464884 1993. Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter.
6593713 1984. Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations.
13601722 1958. Discussion on clinical and laboratory assessment of water and electrolyte disturbances.
24265071 2014. Purinergic signalling in the kidney in health and disease.
29204172 2017. Protective effects of coenzyme Q10 and L-carnitine against statin-induced pancreatic mitochondrial toxicity in rats.
21536154 2011. Characterization of an ATP-sensitive K(+) channel in rat carotid body glomus cells.
34421316 2021. A Literature Review of the Potential Impact of Medication on Vitamin D Status.
31007914 2019. Hypertension in pregnancy: Pathophysiology and treatment.
34121880 2021. 6-Shogaol attenuated ethylene glycol and aluminium chloride induced urolithiasis and renal injuries in rodents.
30202218 2018. Vitamin B12 protects against DNA damage induced by hydrochlorothiazide.
34349180 2021. Acetylation turns leucine into a drug by membrane transporter switching.
32581267 2020. Role of PKC in the Regulation of the Human Kidney Chloride Channel ClC-Ka.
31863073 2019. Deletion of the serine protease CAP2/Tmprss4 leads to dysregulated renal water handling upon dietary potassium depletion.
30209259 2018. Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms.
29323234 2018. Caveolin 1 Promotes Renal Water and Salt Reabsorption.
29021560 2017. The thiazide sensitive sodium chloride co-transporter NCC is modulated by site-specific ubiquitylation.
28646163 2017. Aldosterone Modulates the Association between NCC and ENaC.
26739766 2016. Functional inhibition of urea transporter UT-B enhances endothelial-dependent vasodilatation and lowers blood pressure via L-arginine-endothelial nitric oxide synthase-nitric oxide pathway.
26732173 2016. Osmotic stress induces the phosphorylation of WNK4 Ser575 via the p38MAPK-MK pathway.
26239621 2015. A Systems Level Analysis of Vasopressin-mediated Signaling Networks in Kidney Distal Convoluted Tubule Cells.
22180838 2011. Phosphatidylinositol 4,5-bisphosphate (PIP(2)) controls magnesium gatekeeper TRPM6 activity.
24803536 2014. Chloride sensing by WNK1 involves inhibition of autophosphorylation.
26385481 2016. Role of renal TRP channels in physiology and pathology.
25116874 2014. Plasma magnesium and risk of ischemic stroke among women.
9885099 1998. Outpatient management of congestive heart failure.
23148166 2010. Endocrine and metabolic emergencies: hypercalcaemia.
33447357 2020. Wernicke's encephalopathy - from basic science to clinical practice. Part 1: Understanding the role of thiamine.
24533254 2013. A connected tale of claudins from the renal duct to the sensory system.
26330658 2015. Why Your Mother Was Right: How Potassium Intake Reduces Blood Pressure.
31843024 2019. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
21603593 2011. The causes, consequences, and treatment of left or right heart failure.
6246683 1980. The clinical physiology of water metabolism. Part III: The water depletion (hyperosmolar) and water excess (hyposmolar) syndromes.
388867 1979. Mannitol.
362722 1978. The pathophysiology and clinical aspects of hypercalcemic disorders.
26981195 2016. New insights into sodium transport regulation in the distal nephron: Role of G-protein coupled receptors.
26240698 2015. Respiratory failure in diabetic ketoacidosis.
28101446 2017. Hypertonicity: Clinical entities, manifestations and treatment.
24175253 2012. Proton pump inhibitor-induced hypomagnesemia: A new challenge.
4923380 1970. Signs and symptoms of electrolyte disorders.
6056189 1967. Divalent ion metabolism and osteodystrophy in chronic renal failure.
5973294 1966. Disorders of renal concentrating ability.
C7120502 ä. Mechanisms of Hypersensitivity.
C7170212 2011. Occupational environmental and iatrogenic lung disease.